← brief for 2026-09-03 · Transplant & xeno

eGenesis Announces Clinical Update in Ongoing Expanded Access Study…

Page No results yet Not peer reviewed

Key takeaways

The company eGenesis says five people with kidney failure have received its gene-edited pig kidney since March 2024, through a program that allows treatment outside a formal trial. It expects to start a full clinical trial of the organ, called EGEN-2784, in early 2027. This is a company announcement, not published or reviewed data, and it does not show here how long the transplanted kidneys kept working. There are no results to judge yet.

Source

Page · Forager · 2026-09-04
https://egenesisbio.com/news-media/press-releases/egenesis-announces-clinical-update-in-ongoing-expanded-access-study-of-egen-2784-in-patients-with-kidney-failure